Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 423-340-5 | CAS number: 162881-26-7 CGI 819
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study conducted according to GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 996
- Report date:
- 1996
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Version / remarks:
- (1987)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
Test material
- Reference substance name:
- Phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide
- EC Number:
- 423-340-5
- EC Name:
- Phenyl bis(2,4,6-trimethylbenzoyl)-phosphine oxide
- Cas Number:
- 162881-26-7
- Molecular formula:
- C26 H27 O3 P
- IUPAC Name:
- [phenyl(2,4,6-trimethylbenzoyl)phosphoryl](2,4,6-trimethylphenyl)methanone
- Details on test material:
- - Name of test material (as cited in study report): TKA 40135 (CGI 819)
- Physical state: Pale yellow powder
- Lot/batch No.: 1031/2A
- Purity: 98.4 % (analytical certificate No. 960604/01)
- Expiration date of the lot/batch: November 1997
- Storage of test material: at 4°C in the dark
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Harlan U.K. Ltd., Bicester, Oxon, England
- Age at study initiation: approximately four to seven weeks
- Weight at study initiation: approximately 103 to 121 g
- Fasting period before study: access to food only was prevented overnight prior to and approximately 4 hours after dosing.
- Housing: in groups of up to five rats of the same sex in metal cages
- Diet (e.g. ad libitum): standard laboratory rodent diet (SDS LAD 1), ad libitum
- Water (e.g. ad libitum): drinking water, ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 3°C
- Humidity (%): 30 - 70%
- Air changes (per hr): 10 to 15
- Photoperiod (hrs dark / hrs light): 12hrs/12 hrs
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- The test substance was formulated at a concentration of 20% w/v in distilled water and administered at a volume of 10 mL/kg bw.
The test substance was prepared on the day of dosing. As the test material was advised by the sponsor to be light sensitive, the test formulation was prepared under safelight and the formulation container kept wrapped with tin foil. - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- Five animals per sex and group were used.
- Control animals:
- no
- Details on study design:
- MORTALITY AND CLINICAL SIGNS OF TOXICITY
The animals were checked at least twice daily for any mortalities. They were observed for clinical signs soon after dosing and at frequent
intervals for the remainder of day 1; on subsequent days animals were observed twice a day until ending of the observation period. The animals were observed for 14 days after dosing.
BODYWEIGHT
The bodyweight of each rat was recorded on days 1 (prior to dosing), 8 and 15. Individual weekly bodyweight changes and group mean bodyweights were calculated.
PATHOLOGY
The animals were sacrificed for the purpose of necropsy on day 15 by cervical dislocation. They were subjected to gross pathological examination.
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: no mortalities were observed at the tested dose level of 2000 mg/kg bw.
- Mortality:
- All animals survived the single oral dosage with 2000 mg/kg bw of the test material.
- Clinical signs:
- other: Piloerection was observed in all rats within two minutes of dosing, persisting in all animals throughout day 2 of observation. There were no other clinical signs of toxicity. No more signs were seen from day 3 until the end of the observation period.
- Gross pathology:
- Necropsy was inconspicuous in all animals sacrificed on day 15.
Any other information on results incl. tables
Bodyweight changes:
Sex |
Dose |
Animal Number |
Body weight (g) at |
||
Day 1 |
Day 8 |
Day 15 |
|||
Males |
2000 mg/kg bw |
1 |
121 |
203 |
258 |
2 |
108 |
171 |
208 |
||
3 |
119 |
183 |
228 |
||
4 |
118 |
193 |
252 |
||
5 |
117 |
189 |
236 |
||
mean |
117 |
188 |
236 |
||
Females |
2000 mg/kg bw |
6 |
104 |
142 |
162 |
7 |
118 |
170 |
200 |
||
8 |
104 |
148 |
176 |
||
9 |
103 |
146 |
168 |
||
10 |
118 |
172 |
195 |
||
mean |
109 |
156 |
180 |
Body weight gains during the observation period:
Sex |
Dose |
Animal Number |
Body weight gain (g) for |
|
Week 1 |
Week 2 |
|||
Males |
2000 mg/kg bw |
1 |
82 |
55 |
2 |
63 |
37 |
||
3 |
64 |
45 |
||
4 |
74 |
59 |
||
5 |
71 |
47 |
||
Females |
2000 mg/kg bw |
6 |
38 |
20 |
7 |
52 |
30 |
||
8 |
44 |
28 |
||
9 |
43 |
22 |
||
10 |
54 |
23 |
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.